Wang Xin
Other Government · 4 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | PULSAR Combined With Fecal Microbiota Transplantation for Advanced Hepatocellular Carcinoma Progressing After Hepatocellular Carcinoma (HCC) | Phase 2 | 2026-03-05 |
| Recruiting | PULSAR Combined With Immunotherapy and Chemotherapy Cholangiocarcinoma | Phase 1 / Phase 2 | 2025-11-04 |
| Unknown | Prophylaxis of Graft-versus-host Disease With Anti-CD25 Antibody in Patients Underwent HSCT GVHD | Phase 2 | 2024-03-26 |
| Unknown | Phase IV Observational Study of Orelabrutinib in the Treatment of Chronic Lymphocytic Leukemia/Small Cell Lymp CLL/SLL | — | 2023-07-01 |